Gilead Sciences, Inc. GILD announced positive data from its ongoing phase I study evaluating pipeline candidate, lenacapavir.

Now the Trump administration has put the brakes on foreign aid while alleging it's wasteful, causing chaos in the system that for over 20 years has kept millions of people alive ...

In the general population, frailty is an aging-related risk factor for poor outcomes; individuals experiencing frailty face ...

The United Nations AIDS agency has warned that more than 6 million lives could be at risk over the next four years if the US government cuts off global funding of HIV/AIDS programmes.

Pharma giant Gilead Sciences has revealed the results of its first, Phase 1 trial into a once-a-year PrEP injection. The ...

Data from a very early-phase trial shows that the drug is safe and remains in the body for up to 56 weeks. From two ...

Tiamat Legion Medusa from Texas, who was born Richard Hernandez, had a dream about a snake bite, which they believe turned ...

Chronic kidney disease (CKD) affects approximately 850 million people worldwide and, if left undiagnosed, can progress to ...

HIV is spread by bodily fluids such as blood, breast milk or semen. It gradually weakens the body’s immune system and makes it vulnerable to disease, including ones rarely seen in otherwise healthy ...

HIV is spread by bodily fluids such as blood, breast milk or semen. It gradually weakens the body’s immune system and makes it vulnerable to disease, including ones rarely seen in otherwise ...